Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,296 results for ""Tissue Plasminogen Activator""

Your Filters

Subject : plasminogen activators
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.

  • Authors : Li Y; Department of Anesthesiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.; Zhu ZY

Subjects: Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Intracranial Hemorrhages/Intracranial Hemorrhages/Intracranial Hemorrhages/*chemically induced ; Intracranial Hemorrhages/Intracranial Hemorrhages/Intracranial Hemorrhages/*prevention & control

  • Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2019 Dec; Vol. 25 (12), pp. 1343-1352. Date of Electronic Publication: 2019 Nov 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Fibrinolytic Capacity of Desmoteplase Compared to Tissue Plasminogen Activator in Rabbit Eyes.

  • Authors : Voelter K; 1 Veterinary Ophthalmology, Equine Clinic, Vetsuisse Faculty Zurich, Zurich, Switzerland.; Tappeiner C

Subjects: Eye/Eye/Eye/*drug effects ; Fibrinolytic Agents/Fibrinolytic Agents/Fibrinolytic Agents/*pharmacokinetics ; Ophthalmic Solutions/Ophthalmic Solutions/Ophthalmic Solutions/*pharmacokinetics

  • Source: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2019 Jan/Feb; Vol. 35 (1), pp. Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Prevalence of Imaging Targets in Patients With Minor Stroke Selected for IV tPA Treatment Using MRI: The Treatment of Minor Stroke With MRI Evaluation Study (TIMES).

  • Authors : Hsia AW; From the Stroke Branch (A.W.H., M.L.L., R.L., J.K.L., Z.N., R.T.B., C.K., S.P.B., L.L.), NIH/National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center (A.W.H., R.T.B., C.K., S.P.B.), Washington, DC

Subjects: Ischemic Stroke/Ischemic Stroke/Ischemic Stroke/*diagnostic imaging ; Ischemic Stroke/Ischemic Stroke/Ischemic Stroke/*drug therapy ; Magnetic Resonance Imaging/Magnetic Resonance Imaging/Magnetic Resonance Imaging/*methods

  • Source: Neurology [Neurology] 2021 Mar 02; Vol. 96 (9), pp. e1301-e1311. Date of Electronic Publication: 2021 Jan 20.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Urokinase receptor and tissue plasminogen activator as immediate‐early genes in pentylenetetrazole‐induced seizures in the mouse brain.

Subjects: TISSUE plasminogen activator; PLASMINOGEN activators; UROKINASE

  • Source: European Journal of Neuroscience. Apr2020, Vol. 51 Issue 7, p1559-1572. 14p. 2 Black and White Photographs, 1 Diagram, 6 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The cartilage-specific lectin C-type lectin domain family 3 member A (CLEC3A) enhances tissue plasminogen activator-mediated plasminogen activation.

  • Authors : Lau D; Institute for Clinical Chemistry, University of Cologne, D-50924 Cologne, Germany.; Elezagic D

Subjects: Lectins, C-Type/Lectins, C-Type/Lectins, C-Type/*metabolism ; Plasminogen Activators/Plasminogen Activators/Plasminogen Activators/*metabolism ; Tissue Plasminogen Activator/Tissue Plasminogen Activator/Tissue Plasminogen Activator/*metabolism

  • Source: The Journal of biological chemistry [J Biol Chem] 2018 Jan 05; Vol. 293 (1), pp. 203-214. Date of Electronic Publication: 2017 Nov 16.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

Read More Add to Saved list
×
Academic Journal

Relation of Serum Alpha 2-Antiplasmin to Clinical Response to Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Strokes without Large Vessel Occlusion.

Subjects: *TISSUE plasminogen activator; *ISCHEMIC stroke; *STROKE patients

  • Source: QJM: An International Journal of Medicine. 2024 Supplement, Vol. 117, pii229-ii230. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.

Subjects: Protein Aggregates*; Fibrinolysin/Fibrinolysin/Fibrinolysin/*metabolism ; Microglia/Microglia/Microglia/*drug effects

  • Source: The Journal of biological chemistry [J Biol Chem] 2017 Sep 01; Vol. 292 (35), pp. 14425-14437. Date of Electronic Publication: 2017 Jul 14.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

Read More Add to Saved list
×
Academic Journal

Preoperative co-application of bevacizumab and tissue plasminogen activator in vitrectomy for proliferative diabetic retinopathy.

Subjects: TISSUE plasminogen activator; PLASMINOGEN activators; DIABETIC retinopathy

  • Source: Arquivos Brasileiros de Oftalmologia; 2024, Vol. 87 Issue 2, p1-5, 5p

Record details

Read More Add to Saved list
×
Academic Journal

Ischemic stroke and excellent recovery after administration of intravenous tissue plasminogen activator.

  • Authors : Jain SV; Department of Neurology, Virginia Commonwealth University Medical Center, Richmond, Virginia 23298, USA.; Morton LD

Subjects: Brain Ischemia/Brain Ischemia/Brain Ischemia/*drug therapy ; Plasminogen Activators/Plasminogen Activators/Plasminogen Activators/*therapeutic use ; Stroke/Stroke/Stroke/*drug therapy

  • Source: Pediatric neurology [Pediatr Neurol] 2008 Feb; Vol. 38 (2), pp. 126-9.Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 8508183 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rupture of a thoracic aortic aneurysm: a rare adverse reaction following systemic tissue plasminogen activator infusion.

  • Authors : Hayashi H; Department of Radiology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, 113-8603, Tokyo, Japan, ; Kawamata H

Subjects: Aortic Aneurysm, Thoracic/Aortic Aneurysm, Thoracic/Aortic Aneurysm, Thoracic/*complications ; Aortic Rupture/Aortic Rupture/Aortic Rupture/*chemically induced ; Plasminogen Activators/Plasminogen Activators/Plasminogen Activators/*adverse effects

  • Source: Heart and vessels [Heart Vessels] 2004 Jul; Vol. 19 (4), pp. 208-11.Publisher: Springer Verlag Country of Publication: Japan NLM ID: 8511258 Publication Model: Print Cited Medium: Print ISSN: 0910-8327 (Print)

Record details

Read More Add to Saved list
×
  • 1-10 of  4,296 results for ""Tissue Plasminogen Activator""